Platform

A continuous support and intelligence platform

BioTekk is being developed as a modular platform that connects individual reflection, longitudinal analysis and human-led support. Different functions may be configured according to the setting, intended use and applicable governance requirements.

01 / The individual experience

Space to describe
what is actually
happening

The individual experience is designed around reflection rather than assessment. It is intended to help a person put language to their experience, notice change and decide what to do next — with clear information about what the service is and is not.

01 / CHECK-INS

Conversational check-ins

Users can record how they are feeling in natural language and explore the experiences, pressures and contextual factors that may be influencing their wellbeing.

The conversational interface is intended to support reflection and structured self-expression without presenting itself as a human clinician.

02 / REFLECTION

Guided reflection and journalling

Prompts can help users describe significant events, identify recurring themes and consider practical next steps.

Journal entries can contribute to a longer-term personal record where the user has provided informed consent.

03 / WELLBEING TOOLS

Evidence-informed wellbeing tools

The platform may offer grounding, breathing, behavioural activation, problem-structuring and reflective exercises.

Content should be selected and reviewed through an appropriate clinical-governance process and presented with clear boundaries.

04 / TRENDS

Personal wellbeing trends

Over time, BioTekk is intended to present understandable summaries of change, including patterns in self-reported mood, stress, sleep, social connection and other relevant factors.

These summaries are not diagnoses and should not be interpreted as clinical conclusions.

02 / The professional experience

Prioritisation without displacing professional responsibility

For authorised professionals, the objective is to reduce time spent reconstructing context and to make relevant change visible earlier. Responsibility for assessment, decision and action remains with the human team throughout.

Prioritised review
Authorised professionals may receive a structured view of users who require review, based on configured rules, reported concerns and changes in relevant indicators. The design objective is to support prioritisation while preserving professional responsibility for assessment and action.
Concise summaries
With a lawful basis and appropriate permissions, the platform may prepare summaries of relevant interactions, reported concerns and recent changes. Summaries should remain traceable to source information and should identify uncertainty rather than presenting inference as fact.
Continuity across contact points
BioTekk is intended to reduce information loss between self-directed support, routine monitoring and human contact. Any exchange with external clinical systems will require technical validation, information-governance approval and local configuration.
Review prioritisation · illustrative
Role-appropriate access

BioTekk’s recommended organisational model does not provide managers with individual conversation content. Organisational reporting should be aggregated, access-controlled and governed by clear privacy arrangements agreed before deployment.

03 / How the platform works

From engagement to
longitudinal update

A single interaction moves through five defined stages. Each stage is a separable service, so it can be tested, restricted or reconfigured without changing the others.

01
Engagement

The user begins a check-in through an approved interface and receives clear information about the nature of the service, data use, confidentiality and limitations.

02
Contextual analysis

The system analyses the current interaction in relation to available consented context. It may identify themes, reported symptoms, protective factors, changes and indicators requiring further attention.

03
Support response

The user receives an appropriately bounded response, which may include reflection, clarification, psychoeducation, a wellbeing exercise or encouragement to contact a suitable person or service.

04
Safety evaluation

Configured safety processes evaluate whether the interaction contains indicators that warrant additional signposting, urgent advice or review by an authorised human team.

05
Longitudinal update

Where enabled, relevant information contributes to a longitudinal profile that can help the user and authorised professionals understand change over time.

Consent model
Longitudinal retention, professional visibility and any external data exchange are separately consented and separately configurable. Withdrawal of consent is designed to be actionable, not theoretical.
Boundaries in-product
The service states that it is an AI system, describes what it does not do, and signposts urgent and emergency routes before and during use.
Configurability
Escalation thresholds, notification recipients, retention periods and available wellbeing content are set per deployment with the deploying organisation’s clinical and information-governance leads.
Auditability
Safety decisions, escalations and material configuration changes are intended to be logged so that they can be reviewed after the event.

04 / Research roadmap

Optional biometric
and wearable data.

Heart-rate variability Electrodermal activity Temperature SpO₂

BioTekk’s research roadmap includes the responsible integration of signals such as heart-rate variability, electrodermal activity, temperature and blood-oxygen saturation. Where enabled, these signals are intended to provide additional context alongside self-report — not to stand in place of it.

Such data can be affected by many physiological, behavioural and environmental variables: activity, caffeine, illness, medication, sleep timing, ambient temperature and device placement among them. Treating these signals as direct indicators of mental state would therefore be scientifically unsound.

Explicit limitation

BioTekk will not present individual biometric signals as independent evidence of a mental-health condition. Availability will depend on consent, validation, device compatibility and the intended use of the deployment.

Configure it for
your pathway.

Deployments differ. Tell us about your population, current pathway, escalation capacity and governance contacts, and we will describe what a proportionate first configuration looks like.